Back to Search Start Over

Plasma resistin concentration, hepatic fat content, and hepatic and peripheral insulin resistance in pioglitazone-treated type II diabetic patients.

Authors :
Bajaj, M.
Suraamornkull, S.
Hardies, L. J.
Pratipanawatr, T.
DeFronzo, R. A.
Source :
International Journal of Obesity & Related Metabolic Disorders. Jun2004, Vol. 28 Issue 6, p783-789. 7p.
Publication Year :
2004

Abstract

OBJECTIVES:: To study the effect of pioglitazone (PIO) on plasma resistin concentration, endogenous glucose production (EGP), and hepatic fat content (HFC) in patients with type II diabetes (T2DM). SUBJECTS:: A total of 13 T2DM patients (age=51±2?y, BMI=29.7±1.1?kg/m2, HbA1c=8.0±0.5%). METHODS:: HFC (magnetic resonance spectroscopy) and basal plasma resistin concentration were quantitated before and after PIO treatment (45?mg/day) for 16 weeks. Subjects received a 3?h euglycemic insulin (100?mU/m2/min) clamp with 3-[3H] glucose to determine rates of EGP and tissue glucose disappearance (Rd) before and after PIO. RESULTS:: PIO reduced fasting plasma glucose (10.3±0.7 to 7.6±0.6?mmol/l, P<0.001) and HbA1c (8.0±0.4 to 6.8±0.3%, P<0.001) despite increased body weight (83.2±3.4 to 86.3±3.4?kg, P<0.001). PIO improved Rd (4.9±0.4 to 6.6±0.5?mg/kg/min, P<0.005) and reduced EGP (0.22±0.04 to 0.06±0.02?mg/kg/min, P<0.01) during the insulin clamp. Following PIO, HFC decreased from 21.1±3.5 to 11.2±2.1% (P<0.005), and plasma resistin decreased from 5.3±0.6 to 3.5±0.3?ng/ml (P<0.01). Plasma resistin concentration correlated positively with HFC before (r=0.58, P<0.05) and after (r=0.55, P<0.05) PIO treatment. Taken collectively, plasma resistin concentration, before and after PIO treatment, correlated positively with hepatic fat content (r=0.66, P<0.001) and EGP during the insulin clamp (r=0.41, P<0.05). However, the plasma resistin concentration did not correlate with whole body glucose disposal (Rd) during the insulin clamp either before (r=-0.18, P=NS) or after (r=-0.13, P=NS) PIO treatment. CONCLUSIONS:: PIO treatment in T2DM causes a significant decrease in plasma resistin concentration. The decrease in plasma resistin is positively correlated with the decrease in hepatic fat content and improvement in hepatic insulin sensitivity.International Journal of Obesity (2004) 28, 783-789. doi:10.1038/sj.ijo.0802625 Published online 16 March 2004 [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
03070565
Volume :
28
Issue :
6
Database :
Academic Search Index
Journal :
International Journal of Obesity & Related Metabolic Disorders
Publication Type :
Academic Journal
Accession number :
13121513
Full Text :
https://doi.org/10.1038/sj.ijo.0802625